MONICA RAMIREZ: Open Payments
NPI 1578950036 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,913 in 100 payments from 22 companies in 2025. Trend: 2023 $1,722 · 2024 $1,616 · 2025 $1,913
Food & beverage: $1,868Education: $45
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $212 |
| Novo Nordisk Inc | 13 | $211 |
| Lilly USA, LLC | 9 | $199 |
| ABBVIE INC. | 11 | $173 |
| Abbott Laboratories | 7 | $158 |
| Gilead Sciences, Inc. | 8 | $148 |
| Axsome Therapeutics, Inc. | 5 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $119 |
| Dexcom, Inc. | 5 | $108 |
| SANOFI-AVENTIS U.S. LLC | 5 | $100 |
Products named: JARDIANCE, FREESTYLE LIBRE 3, PREVNAR 20, Auvelity, VRAYLAR, MOUNJARO, Dexcom G6 Transmitter, Rybelsus.
Industry payments across TX — which companies pay providers there.
